๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical application of recombinant human erythropoietin for treatments in patients with head and neck cancer

โœ Scribed by Mamoru Tsukuda; Izumi Mochimatsu; Taro Nagahara; Toshiyuki Kokatsu; Shuji Sawaki; Akira Kubota; Madoka Furkawa; Yasuhiro Arai

Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
503 KB
Volume
36
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The application of a two-stage design fo
The application of a two-stage design for clinical trials in patients with recurrent head and neck cancer
โœ Eisenberger, Mario A. ;Ellenberg, Susan ;Leyland-Jones, Brian ;Friedman, Michael ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 620 KB

Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this

Can biomarkers play a role in the decisi
Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer?
โœ Robert P. Takes; Alessandra Rinaldo; Juan Pablo Rodrigo; Kenneth O. Devaney; Joh ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 157 KB ๐Ÿ‘ 1 views

## Abstract For most patients with head and neck squamous cell cancer, a treatment decision concerning the neck is required. Since detection of small metastases in lymph nodes is difficult, many of the patients with no detectable metastases receive elective treatment of the neck. Additional informa